Compliance Rate
Compliance Rate
51.23%
Compliant submissions
187
Incompliant submissions
178
Total trials
365
My Organizations' Clinical Trials
Showing 1400 of 2400 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 11/30/93
Due: 11/30/94
Phase: N/A
Priority: Normal
Start: -
End: 01/31/00
Due: 01/31/01
Phase: N/A
Priority: Normal
Start: -
End: 07/31/04
Due: 07/31/05
Phase: N/A
Priority: Normal
Start: -
End: 02/29/96
Due: 02/28/97
Phase: N/A
Priority: Normal
Start: -
End: 11/30/93
Due: 11/30/94
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 03/31/03
Due: 03/31/04
Phase: N/A
Priority: Normal
Start: -
End: 09/30/97
Due: 09/30/98
Phase: N/A
Priority: Normal
Start: -
End: 08/31/92
Due: 08/31/93
Phase: N/A
Priority: Normal
Start: -
End: 06/30/91
Due: 06/30/92
Phase: N/A
Priority: Normal
Start: -
End: 08/31/99
Due: 08/31/00
Phase: N/A
Priority: Normal
Start: -
End: 09/30/99
Due: 09/30/00
Phase: N/A
Priority: Normal
Start: -
End: 08/31/92
Due: 08/31/93
Phase: N/A
Priority: Normal
Start: -
End: 03/31/93
Due: 03/31/94
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 12/31/92
Due: 12/31/93
Phase: N/A
Priority: Normal
Start: 02/28/98
End: -
Due: -
The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 11/30/03
Due: 11/30/04
Phase: N/A
Priority: Normal
Start: -
End: 04/30/92
Due: 04/30/93
Phase: N/A
Priority: Normal
Start: -
End: 02/28/90
Due: 02/28/91